Literature DB >> 20553449

Ethical considerations for participation of nondirected living donors in kidney exchange programs.

E S Woodle1, J A Daller, M Aeder, R Shapiro, T Sandholm, V Casingal, D Goldfarb, R M Lewis, J Goebel, M Siegler.   

Abstract

Kidneys from nondirected donors (NDDs) have historically been allocated directly to the deceased donor wait list (DDWL). Recently, however, NDDs have participated in kidney exchange (KE) procedures, including KE 'chains', which have received considerable media attention. This increasing application of KE chains with NDD participation has occurred with limited ethical analysis and without ethical guidelines. This article aims to provide a rigorous ethical evaluation of NDDs and chain KEs. NDDs and bridge donors (BDs) (i.e. living donors who link KE procedures within KE chains) raise several ethical concerns including coercion, privacy, confidentiality, exploitation and commercialization. In addition, although NDD participation in KE procedures may increase transplant numbers, it may also reduce NDD kidney allocation to the DDWL, and disadvantage vulnerable populations, particularly O blood group candidates. Open KE chains (also termed 'never-ending' chains) result in a permanent diversion of NDD kidneys from the DDWL. The concept of limited KE chains is discussed as an ethically preferable means for protecting NDDs and BDs from coercion and minimizing 'backing out', whereas 'honor systems' are rejected because they are coercive and override autonomy. Recent occurrences of BDs backing out argue for adoption of ethically based protective measures for NDD participation in KE.

Entities:  

Mesh:

Year:  2010        PMID: 20553449     DOI: 10.1111/j.1600-6143.2010.03136.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  9 in total

Review 1.  Psychosocial and socioeconomic issues facing the living kidney donor.

Authors:  Mary Amanda Dew; Cheryl L Jacobs
Journal:  Adv Chronic Kidney Dis       Date:  2012-07       Impact factor: 3.620

Review 2.  [Kidney paired donation. Combination with extracorporeal desensitization].

Authors:  G Bond; G A Böhmig
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-08-23       Impact factor: 0.840

3.  Emotional and Financial Experiences of Kidney Donors over the Past 50 Years: The RELIVE Study.

Authors:  Cheryl L Jacobs; Cynthia R Gross; Emily E Messersmith; Barry A Hong; Brenda W Gillespie; Peg Hill-Callahan; Sandra J Taler; Sheila G Jowsey; Tim J Beebe; Arthur J Matas; Jonah Odim; Hassan N Ibrahim
Journal:  Clin J Am Soc Nephrol       Date:  2015-10-13       Impact factor: 8.237

4.  Ethical and Logistical Issues Raised by the Advanced Donation Program "Pay It Forward" Scheme.

Authors:  Lainie Friedman Ross; James R Rodrigue; Robert M Veatch
Journal:  J Med Philos       Date:  2017-10-01

5.  Consideration of donor age and human leukocyte antigen matching in the setting of multiple potential living kidney donors.

Authors:  Michael D Rizzari; Thomas M Suszynski; Kristen J Gillingham; Arthur J Matas
Journal:  Transplantation       Date:  2011-07-15       Impact factor: 4.939

6.  Outcome of kidney paired donation transplantation to increase donor pool and to prevent commercial transplantation: a single-center experience from a developing country.

Authors:  Vivek B Kute; Manoj R Gumber; Himanshu V Patel; Pankaj R Shah; Aruna V Vanikar; Pranjal R Modi; Veena R Shah; Mohan P Patel; Hargovind L Trivedi
Journal:  Int Urol Nephrol       Date:  2012-11-08       Impact factor: 2.370

7.  Utilization of Deceased Donor Kidneys to Initiate Living Donor Chains.

Authors:  M L Melcher; J P Roberts; A B Leichtman; A E Roth; M A Rees
Journal:  Am J Transplant       Date:  2016-03-09       Impact factor: 8.086

8.  The benefit to waitlist patients in a national paired kidney exchange program: Exploring characteristics of chain end living donor transplants.

Authors:  Nathan Osbun; Alvin G Thomas; Mathew Ronin; Matthew Cooper; Stuart M Flechner; Dorry L Segev; Jeffrey L Veale
Journal:  Am J Transplant       Date:  2021-07-17       Impact factor: 9.369

9.  ABO-incompatible kidney transplantation as a renal replacement therapy-A single low-volume center experience in Japan.

Authors:  Akihiro Kosoku; Junji Uchida; Shunji Nishide; Kazuya Kabei; Hisao Shimada; Tomoaki Iwai; Nobuyuki Kuwabara; Keiko Maeda; Toshihide Naganuma; Norihiko Kumada; Yoshiaki Takemoto; Takuma Ishihara; Ayumi Shintani; Tatsuya Nakatani
Journal:  PLoS One       Date:  2018-12-31       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.